CATX
Perspective Therapeutics Inc.
NYSE MKT: CATX · HEALTHCARE · MEDICAL DEVICES
$3.90
-0.89% today
Updated 2026-04-30
Market cap
$514.22M
P/E ratio
—
P/S ratio
581.70x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
Perspective Therapeutics Inc. (CATX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-92,633.00%
ROE
-41.60%
ROA
-23.40%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $4.61M | $-3.68M | 3.63% | -94.13% | -79.91% |
| 2015 | $4.61M | $-3.68M | 3.63% | -94.13% | -79.91% |
| 2016 | $4.77M | $-4.71M | 2.71% | -106.56% | -98.77% |
| 2016 | $4.77M | $-4.71M | 2.71% | -106.56% | -98.77% |
| 2017 | $4.76M | $-6.16M | 17.60% | -132.47% | -129.43% |
| 2017 | $4.76M | $-6.16M | 17.60% | -132.47% | -129.43% |
| 2018 | $5.92M | $-6.70M | 31.10% | -113.61% | -113.12% |
| 2018 | $7.31M | $-4.85M | 41.66% | -72.16% | -66.31% |
| 2019 | $7.31M | $-4.85M | 41.66% | -72.16% | -66.31% |
| 2019 | $9.68M | $-3.27M | 52.93% | -35.91% | -33.77% |
| 2020 | $9.68M | $-3.27M | 52.93% | -35.91% | -33.77% |
| 2020 | $10.05M | $-3.19M | 50.94% | -34.19% | -31.71% |
| 2021 | $10.05M | $-3.19M | 50.94% | -34.19% | -31.71% |
| 2021 | $10.79M | $-7.27M | 42.76% | -68.47% | -67.36% |
| 2022 | $10.79M | $-7.15M | 42.76% | -68.47% | -66.26% |
| 2022 | $7.10M | $-14.67M | 23.00% | -213.71% | -206.50% |
| 2023 | $7.10M | $-14.67M | 23.00% | -213.71% | -206.50% |
| 2023 | $1.43M | $-46.51M | 100.00% | -2,855.02% | -3,243.24% |
| 2024 | $0.00 | $-79.28M | — | — | — |
| 2025 | $0.00 | $-103.12M | — | — | — |